BioAdaptives, Inc. BDPT
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0014 Day range 0.0014
0.0008 52-week range 0.06
- YTD
- -93.21%
- 1 year
- -95.35%
- Open
- 0.0014
- Prev close
- 0.0015
- Mkt cap
- 295.39K
- Vol
- 745.00K
- Avg vol
- 21.75M
- EPS
- -0.11
- P/E
- 0.00
More statistics
- Low
- 0.0014
- High
- 0.0014
6M chart
Signals (25)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| RSI: Oversold | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| RSI: Oversold | Jun 18, 2026 | 4 months ago |
| RSI: Oversold | Jun 9, 2026 | 4 months ago |
| RSI: Oversold | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
News
- BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
- BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress
- UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)
- BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update
- BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
- BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
- BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
- BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
- BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
- BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
Your note
Sign in to keep a note on BDPT — it syncs with the Stock Master app.